Laparascopic Surgery Does Not Improve Outcomes Over Open Resection for Rectal Cancer
the ONA take:
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer, two studies published in JAMA have shown.
In the first study, researchers sought to determine whether laparoscopic resection is noninferior to open resection in patients with more advanced-stage rectal cancer.
Researchers randomly assigned 240 patients to undergo laparoscopic resection and 222 to undergo open resection. Results showed that the minimally invasive surgery did not improve cancer control as well as the open surgery did.
“Pending clinical oncologic outcomes, the findings do not support the use of laparoscopic resection in these patients,” the authors of the first study conclude.
In the second study, researchers enrolled 475 patients with T1 to T3 rectal adenocarcinoma less than 15 cm from the anal verge and randomly assigned them to undergo open laparotomy and rectal resection or laparoscopic rectal resection.
Results of this study also demonstrated that laparoscopic surgery was not noninferior to open surgery for successful resection; however, overall quality of surgery was high among patients who underwent the laparoscopic surgery.
“The findings do not provide sufficient evidence for the routine use of laparoscopic surgery,” the authors of the second study conclude.
Compared with open surgery, laparascopic surgery fails to improve outcomes for patients with stage 2 or 3 rectal cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|